Atria Wealth Solutions’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208K | Sell |
5,375
-4,195
| -44% | -$162K | ﹤0.01% | 1373 |
|
|
2025
Q1 | $371K | Sell |
9,570
-11,195
| -54% | -$434K | ﹤0.01% | 1350 |
|
|
2024
Q4 | $702K | Sell |
20,765
-5,040
| -20% | -$170K | 0.01% | 1065 |
|
|
2024
Q3 | $1.06M | Sell |
25,805
-8,133
| -24% | -$333K | 0.01% | 886 |
|
|
2024
Q2 | $1.31M | Buy |
33,938
+3,310
| +11% | +$128K | 0.01% | 778 |
|
|
2024
Q1 | $1.32M | Sell |
30,628
-1,390
| -4% | -$60K | 0.01% | 789 |
|
|
2023
Q4 | $1.19M | Buy |
32,018
+3,736
| +13% | +$139K | 0.01% | 790 |
|
|
2023
Q3 | $1.03M | Sell |
28,282
-2,044
| -7% | -$74.4K | 0.01% | 795 |
|
|
2023
Q2 | $1.08M | Sell |
30,326
-284
| -0.9% | -$10.1K | 0.01% | 800 |
|
|
2023
Q1 | $1.1M | Buy |
30,610
+8,905
| +41% | +$319K | 0.02% | 759 |
|
|
2022
Q4 | $766K | Sell |
21,705
-9,076
| -29% | -$320K | 0.01% | 881 |
|
|
2022
Q3 | $910K | Buy |
30,781
+6,887
| +29% | +$204K | 0.02% | 743 |
|
|
2022
Q2 | $1.31M | Sell |
23,894
-5,824
| -20% | -$318K | 0.02% | 567 |
|
|
2022
Q1 | $1.64M | Buy |
+29,718
| New | +$1.64M | 0.03% | 547 |
|